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was included in the analysis. The authors stated that all patients were referred to the teleophthalmology service. A consensus process was then conducted at the end of the technology transfer project. This involved ophthalmologists reviewing the case notes of patients who had received teleophthalmology. The consensus method judged whether clinical outcomes (as well as costs) were attributable to teleophthalmology (definitely related, possibly related or not related). Overall, a sample of 113 patients was referred for teleophthalmology. Of these, case notes were available for 90. The mean age was 26 years. No other information on the patients included in the study was provided. However, the patients attending the hospital were mainly of Zulu origin. It was not stated whether some patients were excluded from the study sample or refused to participate.
Study design
This was a case series study, with clinical data coming from a review of the patients' charts. The evidence was obtained from a single centre, the Edendale Hospital in Edendale, KwaZulu-Natal in South Africa. Details of the follow-up were not reported, but the effectiveness data were gathered alongside a project that ran for 12 months.
Analysis of effectiveness
Only those patients where teleophthalmology had definitely or possibly led to an improvement in visual health, as measured by an improvement in visual acuity, were included.
The primary outcome measure was the change in visual acuity identified by the consensus process. The secondary outcome measures, which were used in the calculation of the benefit measure, were the duration of disability, mean age of onset, mean disability weight (estimated using an equation converting the measure of visual acuity before teleophthalmology into a utility), and age weighting. Four measures of practitioner benefit were also estimated:
practitioner satisfaction with the quality of images produced; practitioner comfort with the process; a measure of the reason for seeking specialist advice; and the impact on medical education.
Effectiveness results
The mean duration of disability was 10 years (chronic disease, estimated as part of the consensus process).
The mean age of onset was 31.1 years.
The mean disability weight was 0.45 in the absence of teleophthalmology and 0.36 with teleophthalmology.
The age weighting was 0.04.
The analysis of benefit measures showed the following results: in 41% of cases, practitioners perceived the quality of the images to be high; in 49% of cases, practitioners reported high comfort with the process; in 72% of cases, the reason for local practitioners seeking specialist advice was that a consultant was not available locally; 10 novel procedures were identified during the technology transfer process.
Clinical conclusions
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The effectiveness analysis showed that the use of teleophthalmology reduced the disability weight. The clinical data obtained from the consensus methods were used as inputs for the calculation of the final benefit measure.
Measure of benefits used in the economic analysis
The summary benefit measure used was the disability-adjusted life-years (DALYs). These were calculated using published methodology. The mean life expectancy used to estimate the DALYs was derived from age-and genderspecific life tables for South Africa. An annual discount rate of 3% was applied.
Direct costs
An annual discount rate of 6% was used for equipment costs with a life span of 5 years or over. The unit costs were not presented separately from the quantities of resources used. The health services included in the economic evaluation were set-up costs, running costs, clinical examination, test and investigation costs attributable to teleophthalmology; and inpatient admission costs. The set-up costs covered equipment (videoconferencing, slit lamps, cameras, video recorders, cabling and maintenance), installation of the telecommunication (ISDN) lines in UK and South Africa, and training. The running costs included the staff costs of those involved in the consultation in UK and South Africa, and the telecommunication costs associated with each teleconsultation.
The cost/resource boundary of the study unclear. The resource use data was estimated using patient-level data derived from the sample of patients included in the clinical study. Local sources were generally used when estimating the unit costs. The price year was 2000.
Statistical analysis of costs
The costs were treated deterministically.
Indirect Costs
The indirect costs were not included in the economic evaluation.
Currency
The costs were estimated in South African Rand and then converted into UK pounds sterling (). The conversion rate in November 2001 was 1 = Rand 10.04.
Sensitivity analysis
A univariate sensitivity analysis was performed to examine the robustness of the cost-utility ratio to changes in the duration of disability and the number of patients whose benefits were directly attributable to teleophthalmology. The authors set the ranges of values used.
Estimated benefits used in the economic analysis
The estimated DALYs averted with teleophthalmology in comparison with conventional care were 6.8. When only patients who had improved visual acuity were considered (57 patients), the estimated DALYs were 10.4.
Cost results
The incremental total cost per consultation with teleophthalmology in comparison with conventional care was 359 (242 for set-up costs, 91 for running costs, and 26 for costs of clinical examinations, tests, investigations and admissions).
The teleophthalmology service, which provided specialist advice to practitioners in South Africa, led to a cost per disability-adjusted life-year (DALY) of 53. This was in the range of thresholds used for cost-effectiveness suggested in developing countries. Further, the telemedicine service also resulted in clear benefits for practitioners in the remote site (the developing country).
CRD COMMENTARY -Selection of comparators
The selection of the comparator (conventional care) was appropriate as it reflected the standard pattern of care for patients referred for an ophthalmic visit. You should decide whether this represents a valid comparator in your own setting.
Validity of estimate of measure of effectiveness
The effectiveness analysis used evidence coming from a single group of patients who attended the new telemedicine service. The changes in clinical outcomes due to the new intervention, compared with standard care, were defined by experts' opinions rather than an objective process. In fact, no control group was used because the authors stated that it would have been unethical to exclude some patients (those potentially included in the control arm) from a more advanced technology. Information on the follow-up and clinical results was unclear. No justification for the size of the sample of patients was provided. These issues tend to limit the validity of the clinical analysis.
Validity of estimate of measure of benefit
The use of DALYs as the summary benefit measure was appropriate as they represent a commonly used measure for interventions implemented in developing countries. DALYs are comparable with the benefits of other health care interventions. DALYs incorporate two dimensions of health (disability and survival). A published approach was used to derive the disability weights. Expected survival was discounted.
Validity of estimate of costs
The perspective adopted in the study was not explicitly stated. A detailed breakdown of the cost items was provided, but the unit costs were not provided separately from the quantities of resources used. In fact, the costs were presented as macro-categories, which limits the possibility of replicating the cost analysis in other settings. The source of the data was reported and, in general, local charges were used. The price year was reported, which aids reflation exercises in other settings. The cost estimates were treated deterministically and were specific to the study settings. No economic estimates were varied in the sensitivity analysis.
Other issues
